home / India / Hikal

Hikal Market Cap

$0.52 B

-0.01 B

NSE:HIKAL.NS · January 22, 2025

Share price

$4.19

Enterprise Value

$55.81 B

Change (1-Year)

29.1%

Global Rank

#6072

Country Rank

#435

Regions

India

Market cap

As of January 22, 2025, Hikal (HIKAL.NS) has a market cap of $0.52 billion USD. According to our data, Hikal is ranked No.6072 in global market value.

Sector Rank:

Biotech #344 Pharmaceuticals #313

HIKAL.NS Market Capitalization Growth

30D Growth:

-1.0%

1 Years Growth:

29.1%

3 Years Growth:

-4.1%

5 Years Growth:

187.9%

10 Years Growth:

279.9%

15 Years Growth:

680.8%

20 Years Growth:

714.0%

Total Growth:

4123%

Hikal Market Cap Chart

YTD

10Y

15Y

20Y

MAX

Hikal Market Cap CAGR Chart

Hikal Market Cap History 2002 - 2025

Year	Market Cap	%Change
Jan 22, 2025	$0.52 B	-7.19%
Dec 31, 2024	$0.56 B	28.98%
Dec 29, 2023	$0.43 B	-25.60%
Dec 30, 2022	$0.58 B	-21.80%
Dec 31, 2021	$0.74 B	223.60%
Dec 31, 2020	$0.23 B	45.73%
Dec 31, 2019	$0.16 B	-26.11%
Dec 31, 2018	$0.21 B	0.71%
Dec 29, 2017	$0.21 B	10.04%
Dec 30, 2016	$0.19 B	29.20%
Dec 31, 2015	$0.15 B	11.16%
Dec 31, 2014	$0.13 B	65.92%
Dec 31, 2013	$80.66 M	-7.55%
Dec 31, 2012	$87.25 M	115.46%
Dec 30, 2011	$40.49 M	-34.05%
Dec 31, 2010	$61.40 M	-14.11%
Dec 31, 2009	$71.49 M	77.67%
Dec 31, 2008	$40.23 M	-46.92%
Dec 31, 2007	$75.80 M	28.32%
Dec 29, 2006	$59.07 M	-36.16%
Dec 30, 2005	$92.53 M	46.02%
Dec 31, 2004	$63.37 M	19.07%
Dec 31, 2003	$53.22 M	288.47%
Dec 31, 2002	$13.70 M	100%

Similar Companies to Hikal

Name	Market Cap	Market cap difference	Regions
Eli Lilly LLY	$678.07 B	0.022 M	USA
Novo Nordisk A/S NOVO-B.CO	$364.73 B	95.429 B	Denmark
Johnson & Johnson JNJ	$349.75 B	0.001 M	USA
Novo Nordisk NVO	$335.24 B	64.098 B	Denmark
AbbVie ABBV	$299.00 B	-0.007 M	USA
Roche ROG.SW	$243.80 B	38.055 B	Switzerland
Merck MRK	$242.04 B	-0.000 M	USA
Thermo Fisher Scientific TMO	$219.78 B	-0.008 M	USA
AstraZeneca AZN	$211.49 B	0.007 M	UK
Novartis NVS	$196.27 B	-0.007 M	Switzerland
Pfizer PFE	$147.40 B	-0.003 M	USA
Amgen AMGN	$146.98 B	0.004 M	USA
Sanofi SNY	$129.14 B	0.001 M	France
Gilead Sciences GILD	$115.95 B	0.002 M	USA
Bristol-Myers Squibb BMY	$115.79 B	-0.003 M	USA
Vertex Pharmaceuticals VRTX	$110.22 B	0.001 M	USA
CSL CSL.AX	$82.04 B	-0.000 M	Australia
Zoetis ZTS	$75.18 B	-0.001 M	USA
Regeneron Pharmaceuticals REGN	$74.73 B	1.236 B	USA
Chugai Pharmaceutical 4519.T	$69.56 B	0.452 B	Japan

About Hikal Inc.

Name

HIKAL LIMITED

Website

https://www.hikal.com

Headquarters

Navi Mumbai,None

symbol

HIKAL.NS

CURRENCY

INR

country

India

fullTimeEmployees

2061

exchange

NSI

firstTradeDateEpochUtc

2002/07/01

HIKAL.NS Market Cap Formula

Market Cap	=	HIKAL.NS Stock Price	*	HIKAL.NS Shares Outstanding
	=	$4.19	*	0.12 B
	=	$0.52 B

What is Market Cap?

Market capitalization represents the market's valuation of a company, calculated by multiplying the current share price by the total number of outstanding shares. It helps to assess the company's size and allows for comparison with other companies.

Material

wikipedia Share_price outstanding

What is Market Capitalization?

Market capitalization, or market cap, is a key measure of a company's market value. It is calculated by multiplying the current stock price by the total number of outstanding shares. Market cap is often used by investors to assess a company's size, stability, and market presence. For any inquiries or to report an issue, please email us at [email protected].

Disclaimer

This website provides general information only. While we aim for accuracy, we do not guarantee data completeness or reliability. Consult a financial advisor before investing. We are not responsible for any losses or damages from using this site. By using it, you agree to these terms. Company logos belong to their respective copyright holders and are shown for editorial purposes only. Prices are not in real time.

America

Europe